STOCK TITAN
  1. Home
  2. XLRN

Acceleron (XLRN) Stock Price, News & Analysis

XLRN NASDAQ

Company Description

Acceleron (NASDAQ: XLRN) is classified in the biological product (except diagnostic) manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for XLRN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
61.1M
Shares outstanding

Latest News

View All
—

Merck Completes Acquisition of Acceleron Pharma Inc.

acquisition
—

Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.

acquisition
+3.28%

Avoro Capital Urges Acceleron Shareholders Not to Tender Into Merck’s Inadequate Offer

+3.28%

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period and Extension of Tender Offer to Acquire Acceleron Pharma Inc.

acquisition
-0.57%

Avoro Capital Releases Presentation Detailing Why Acceleron Shareholders Should Not Tender Into Merck’s Inadequate Offer

+0.16%

Merck Announces Receipt of Antitrust Clearance in Germany and Austria Relating to Tender Offer to Acquire Acceleron Pharma Inc.

acquisition

Acceleron has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, earnings. View all XLRN news →

SEC Filings

View All

No SEC filings available for XLRN.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

XLRN Company Profile & Sector Positioning

Acceleron (XLRN) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.